Who owns GYRE THERAPEUTICS INCORPORATED?
- Ticker: GYRE
- CUSIP Number: 403783103
Tip: Access positions for across all investors
Analyze quarterly positions in Gyre Therapeutics Incorporated with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Gyre Therapeutics Incorporated stock
Who bought or sold GYRE THERAPEUTICS INCORPORATED this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| BlackRock | 514k | $6.5M | 100% | Sep 2024 |
|
| BlackRock | 500k | $6.0M | 191% | Jun 2024 |
|
| Geode Capital Management | 304k | $3.8M | 17% | Sep 2024 |
|
| Vanguard Group | 232k | $2.8M | 19% | Jun 2024 |
|
| Charles Schwab Investment Management | 114k | $1.4M | 392% | Sep 2024 |
|
| State Street Corporation | 96k | $1.1M | 137% | Jun 2024 |
|
| Northern Trust | 95k | $1.2M | 294% | Sep 2024 |
|
| Belvedere Trading | 23k | $282k | 13% | Sep 2024 |
|
| Bank of New York Mellon | 13k | $157k | -32% | Sep 2024 |
|
| Rhumbline Advisers | 10k | $131k | 1% | Sep 2024 |
|
| Barclays | 9.3k | $116k | 282% | Sep 2024 |
|
| Morgan Stanley | 7.3k | $87k | 27% | Jun 2024 |
|
| Citigroup | 5.1k | $64k | 225% | Sep 2024 |
|
| Bank of America Corporation | 4.9k | $62k | -1% | Sep 2024 |
|
| Mirae Asset Global Etfs Holdings | 3.9k | $48k | 100% | Sep 2024 |
|
| Wells Fargo & Company | 3.1k | $39k | 4% | Sep 2024 |
|
| Jpmorgan Chase & Co | 3.0k | $38k | 2% | Sep 2024 |
|
| New York State Common Retirement Fund | 2.7k | $34k | -74% | Sep 2024 |
|
| Bnp Paribas Arbitrage, Snc | 1.9k | $24k | 274% | Sep 2024 |
|
| Royal Bank of Canada | 964.00 | $11k | -8% | Sep 2024 |
|
| Summit Investment Advisors | 683.00 | $8.6k | 0% | Sep 2024 |
|
| Activest Wealth Management | 533.00 | $6.7k | 0% | Sep 2024 |
|
| California State Teachers Retirement System | 505.00 | $6.3k | 0% | Sep 2024 |
|
| Advisor Group Holdings | 441.00 | $5.5k | 3050% | Sep 2024 |
|
| Tower Research Capital | 249.00 | $3.0k | -91% | Jun 2024 |
|
| Amalgamated Bank | 241.00 | $3.0k | 0% | Sep 2024 |
|
| NISA Investment Advisors | 84.00 | $1.1k | 100% | Sep 2024 |
|
| CWM | 30.00 | $0 | 100% | Sep 2024 |
|
| Sterling Capital Management | 21.00 | $262.999800 | 100% | Sep 2024 |
|
| Covestor | 6.00 | $0 | 100% | Sep 2024 |
|
| Capital Performance Advisors | 6.00 | $75.000000 | 100% | Sep 2024 |
|
Who sold out of Gyre Therapeutics Incorporated?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Goldman Sachs Group | Mar 2024 | 46k | $806k |
| Winton Capital | Jun 2024 | 19k | $220k |
| Balyasny Asset Management | Mar 2024 | 14k | $244k |
| Renaissance Technologies | Jun 2024 | 14k | $166k |
| Marshall Wace | Jun 2024 | 11k | $128k |
| Qube Research & Technologies | Mar 2024 | 6.2k | $109k |
| Macquarie Group | Mar 2024 | 408.00 | $7.017600 |